BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
February 17, 2026 18:22 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Viraj Profiles Signs MoU with The Ministry of Steel Under PLI Scheme, Commits INR 280 Crore to Advance Speciality Stainless Steel Manufacturing
MUMBAI, India, Feb. 12, 2026 /PRNewswire/ -- Viraj Profiles Pvt. Ltd. has signed…
ASML reports transactions under its current share buyback program
February 09, 2026 08:00 ET | Source: ASML Netherlands BV ASML reports…
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass.,…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 06, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2026 16:05 ET | Source: Candel Therapeutics NEEDHAM, Mass., Feb.…
Enfinity Global achieves Commercial Operation of First Project Under its 366 MW portfolio of PPAs with Microsoft
MILAN, Jan. 29, 2026 /PRNewswire/ -- Enfinity Global announced today the commercial…
CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Grand Marathon Under Mumbai Climate Week Mobilizes Over 1,500 Students and Children for Climate Action
MUMBAI, India, Jan. 27, 2026 /PRNewswire/ -- In the run up to…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
